Biomedical Engineering Reference
In-Depth Information
21. Hlavacek, W.S., Faeder, J.R., Blinov, M.L., Posner, R.G., Hucka, M., Fontana, W.: Rules for
modeling signal-transduction systems. Sci. STKE. 2006(344), re6 (2006)
22. Postovit, L.M., Seftor, E.A., Seftor, R.E., Hendrix, M.J.: Influence of the microenvironment
on melanoma cell fate determination and phenotype. Cancer Res. 66(16), 7833-7836 (2006)
23. Hendrix, M.J., Seftor, E.A., Seftor, R.E., Kasemeier-Kulesa, J., Kulesa, P.M., Postovit, L.M.:
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat. Rev.
Cancer 7(4), 246-255 (2007). 10.1038/nrc2108, nrc2108 [pii]
24. Zhang, L., Wang,
Z., Sagotsky, J.A., Deisboeck,
T.S.: Multiscale
agent-based
cancer
modeling. J. Math. Biol. 58(4-5), 545-559 (2009)
25. Oda, K., Matsuoka, Y., Funahashi, A., Kitano, H.: A comprehensive pathway map of
epidermal growth factor receptor signaling. Mol. Syst. Biol. 1(2005), 0010 (2005)
26. Friedl, P., Wolf, K.: Tumour-cell invasion and migration: diversity and escape mechanisms.
Nat. Rev. Cancer 3(5), 362-374 (2003)
27. Hatakeyama, M., Kimura, S., Naka, T., Kawasaki, T., Yumoto, N., Ichikawa, M., Kim, J.H.,
Saito, K., Saeki, M., Shirouzu, M., Yokoyama, S., Konagaya, A.: A computational model on
the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-
induced ErbB signalling. Biochem. J. 373(Pt 2), 451-463 (2003)
28. Kholodenko, B.N., Demin, O.V., Moehren, G., Hoek, J.B.: Quantification of short term
signaling by the epidermal growth factor receptor. J. Biol. Chem. 274(42), 30169-30181 (1999)
29. Schoeberl, B., Eichler-Jonsson, C., Gilles, E.D., Muller, G.: Computational modeling of the
dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.
Nat. Biotechnol. 20(4), 370-375 (2002)
30. Mouneimne, G., Soon, L., DesMarais, V., Sidani, M., Song, X., Yip, S.C., Ghosh, M., Eddy, R.,
Backer, J.M., Condeelis, J.: Phospholipase C and cofilin are required for carcinoma cell
directionality in response to EGF stimulation. J. Cell Biol. 166(5), 697-708 (2004)
31. Dittmar, T., Husemann, A., Schewe, Y., Nofer, J.R., Niggemann, B., Zanker, K.S., Brandt, B.H.:
Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation
of tyrosine 1248 of c-erbB-2 receptor via EGFR. Faseb. J. 16(13), 1823-1825 (2002)
32. Santos, S.D., Verveer, P.J., Bastiaens, P.I.: Growth factor-induced MAPK network topology
shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9(3), 324-330 (2007)
33. Athale, C., Mansury, Y., Deisboeck, T.S.: Simulating the impact of a molecular decision-
process on cellular phenotype and multicellular patterns in brain tumors. J. Theor. Biol.
233(4), 469-481 (2005)
34. Athale, C.A., Deisboeck, T.S.: The effects of EGF-receptor density on multiscale tumor
growth patterns. J. Theor. Biol. 238(4), 771-779 (2006)
35. Lund-Johansen, M., Bjerkvig, R., Humphrey, P.A., Bigner, S.H., Bigner, D.D., Laerum, O.D.:
Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.
Cancer Res. 50(18), 6039-6044 (1990)
36. Zhang, L., Athale, C.A., Deisboeck, T.S.: Development of a three-dimensional multiscale
agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and
multicellular patterns in brain cancer. J. Theor. Biol. 244(1), 96-107 (2007)
37. Alarcon, T., Byrne, H.M., Maini, P.K.: A mathematical model of the effects of hypoxia on the
cell-cycle of normal and cancer cells. J. Theor. Biol. 229(3), 395-411 (2004)
38. Zhang, L., Strouthos, C.G., Wang, Z., Deisboeck, T.S.: Simulating brain tumor heterogeneity
with
a
multiscale
agent-based
model:
linking
molecular
signatures,
phenotypes
and
expansion rate. Math. Comput. Model. 49(1-2), 307-319 (2009)
39. Steinbach, J.P., Klumpp, A., Wolburg, H., Weller, M.: Inhibition of epidermal growth factor
receptor signaling protects human malignant glioma cells from hypoxia-induced cell death.
Cancer Res. 64(5), 1575-1578 (2004)
40. Wang, Z., Zhang, L., Sagotsky, J., Deisboeck, T.S.: Simulating non-small cell lung cancer
with a multiscale agent-based model. Theor. Biol. Med. Model. 4(1), 50 (2007)
41. Price, J.T., Wilson, H.M., Haites, N.E.: Epidermal growth factor (EGF) increases the in vitro
invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704.
Eur. J. Cancer 32A(11), 1977-1982 (1996)
Search WWH ::




Custom Search